Literature DB >> 28666115

IFNγ-Dependent Tissue-Immune Homeostasis Is Co-opted in the Tumor Microenvironment.

Christopher J Nirschl1, Mayte Suárez-Fariñas2, Benjamin Izar3, Sanjay Prakadan4, Ruth Dannenfelser5, Itay Tirosh6, Yong Liu1, Qian Zhu5, K Sanjana P Devi1, Shaina L Carroll4, David Chau1, Melika Rezaee7, Tae-Gyun Kim1, Ruiqi Huang8, Judilyn Fuentes-Duculan9, George X Song-Zhao1, Nicholas Gulati9, Michelle A Lowes9, Sandra L King1, Francisco J Quintana10, Young-Suk Lee5, James G Krueger9, Kavita Y Sarin7, Charles H Yoon11, Levi Garraway12, Aviv Regev13, Alex K Shalek14, Olga Troyanskaya15, Niroshana Anandasabapathy16.   

Abstract

Homeostatic programs balance immune protection and self-tolerance. Such mechanisms likely impact autoimmunity and tumor formation, respectively. How homeostasis is maintained and impacts tumor surveillance is unknown. Here, we find that different immune mononuclear phagocytes share a conserved steady-state program during differentiation and entry into healthy tissue. IFNγ is necessary and sufficient to induce this program, revealing a key instructive role. Remarkably, homeostatic and IFNγ-dependent programs enrich across primary human tumors, including melanoma, and stratify survival. Single-cell RNA sequencing (RNA-seq) reveals enrichment of homeostatic modules in monocytes and DCs from human metastatic melanoma. Suppressor-of-cytokine-2 (SOCS2) protein, a conserved program transcript, is expressed by mononuclear phagocytes infiltrating primary melanoma and is induced by IFNγ. SOCS2 limits adaptive anti-tumoral immunity and DC-based priming of T cells in vivo, indicating a critical regulatory role. These findings link immune homeostasis to key determinants of anti-tumoral immunity and escape, revealing co-opting of tissue-specific immune development in the tumor microenvironment.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  IFNγ; dendritic cells; differentiation; homeostasis; immunotherapy; melanoma; suppressor-of-cytokine-signaling 2 (SOCS2); tissue mononuclear phagocytes; tolerance; tumor microenvironment

Mesh:

Substances:

Year:  2017        PMID: 28666115      PMCID: PMC5569303          DOI: 10.1016/j.cell.2017.06.016

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  52 in total

1.  Dichotomous effects of IFN-γ on dendritic cell function determine the extent of IL-12-driven antitumor T cell immunity.

Authors:  Jamie L Harden; Tao Gu; Mehmet O Kilinc; Rachael B Rowswell-Turner; Lauren P Virtuoso; Nejat K Egilmez
Journal:  J Immunol       Date:  2011-06-01       Impact factor: 5.422

2.  IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39.

Authors:  Ivan D Mascanfroni; Ada Yeste; Silvio M Vieira; Evan J Burns; Bonny Patel; Ido Sloma; Yan Wu; Lior Mayo; Rotem Ben-Hamo; Sol Efroni; Vijay K Kuchroo; Simon C Robson; Francisco J Quintana
Journal:  Nat Immunol       Date:  2013-09-01       Impact factor: 25.606

3.  Normal proportion and expression of maturation markers in migratory dendritic cells in the absence of germs or Toll-like receptor signaling.

Authors:  Nicholas S Wilson; Louise J Young; Fiona Kupresanin; Shalin H Naik; David Vremec; William R Heath; Shizuo Akira; Ken Shortman; Jeff Boyle; Eugene Maraskovsky; Gabrielle T Belz; José A Villadangos
Journal:  Immunol Cell Biol       Date:  2007-11-20       Impact factor: 5.126

4.  Skin-derived dendritic cells can mediate deletional tolerance of class I-restricted self-reactive T cells.

Authors:  Jason Waithman; Rhys S Allan; Hiroshi Kosaka; Hiroaki Azukizawa; Ken Shortman; Manfred B Lutz; William R Heath; Francis R Carbone; Gabrielle T Belz
Journal:  J Immunol       Date:  2007-10-01       Impact factor: 5.422

Review 5.  Interferons, immunity and cancer immunoediting.

Authors:  Gavin P Dunn; Catherine M Koebel; Robert D Schreiber
Journal:  Nat Rev Immunol       Date:  2006-11       Impact factor: 53.106

Review 6.  The two faces of interferon-γ in cancer.

Authors:  M Raza Zaidi; Glenn Merlino
Journal:  Clin Cancer Res       Date:  2011-06-24       Impact factor: 12.531

7.  Melanoma progression.

Authors:  David E Elder
Journal:  Pathology       Date:  2016-01-16       Impact factor: 5.306

8.  Statistical significance of variables driving systematic variation in high-dimensional data.

Authors:  Neo Christopher Chung; John D Storey
Journal:  Bioinformatics       Date:  2014-10-21       Impact factor: 6.937

9.  Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor.

Authors:  Veit Rothhammer; Ivan D Mascanfroni; Lukas Bunse; Maisa C Takenaka; Jessica E Kenison; Lior Mayo; Chun-Cheih Chao; Bonny Patel; Raymond Yan; Manon Blain; Jorge I Alvarez; Hania Kébir; Niroshana Anandasabapathy; Guillermo Izquierdo; Steffen Jung; Nikolaus Obholzer; Nathalie Pochet; Clary B Clish; Marco Prinz; Alexandre Prat; Jack Antel; Francisco J Quintana
Journal:  Nat Med       Date:  2016-05-09       Impact factor: 53.440

10.  Targeted exploration and analysis of large cross-platform human transcriptomic compendia.

Authors:  Qian Zhu; Aaron K Wong; Arjun Krishnan; Miriam R Aure; Alicja Tadych; Ran Zhang; David C Corney; Casey S Greene; Lars A Bongo; Vessela N Kristensen; Moses Charikar; Kai Li; Olga G Troyanskaya
Journal:  Nat Methods       Date:  2015-01-12       Impact factor: 28.547

View more
  78 in total

1.  Human bone marrow assessment by single-cell RNA sequencing, mass cytometry, and flow cytometry.

Authors:  Karolyn A Oetjen; Katherine E Lindblad; Meghali Goswami; Gege Gui; Pradeep K Dagur; Catherine Lai; Laura W Dillon; J Philip McCoy; Christopher S Hourigan
Journal:  JCI Insight       Date:  2018-12-06

Review 2.  New advances in immunotherapy for non-small cell lung cancer.

Authors:  Haifeng Qin; Fang Wang; Hui Liu; Zhen Zeng; Shasha Wang; Xin Pan; Hongjun Gao
Journal:  Am J Transl Res       Date:  2018-08-15       Impact factor: 4.060

3.  Melanoma to Vitiligo: The Melanocyte in Biology & Medicine-Joint Montagna Symposium on the Biology of Skin/PanAmerican Society for Pigment Cell Research Annual Meeting.

Authors:  Sancy A Leachman; Thomas J Hornyak; Greg Barsh; Boris C Bastian; Douglas E Brash; James E Cleaver; Cynthia D Cooper; John A D'Orazio; Mayumi Fujita; Sheri L Holmen; Arup K Indra; Kenneth H Kraemer; I Caroline Le Poole; Roger S Lo; Amanda W Lund; Prashiela Manga; William J Pavan; Vijayasaradhi Setaluri; Clara E Stemwedel; Molly F Kulesz-Martin
Journal:  J Invest Dermatol       Date:  2019-07-23       Impact factor: 8.551

4.  Tumour immunology: Tumours copy to escape.

Authors:  Ulrike Harjes
Journal:  Nat Rev Cancer       Date:  2017-07-25       Impact factor: 60.716

Review 5.  IFNγ: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy.

Authors:  Lionel B Ivashkiv
Journal:  Nat Rev Immunol       Date:  2018-09       Impact factor: 53.106

6.  Critical role of post-transcriptional regulation for IFN-γ in tumor-infiltrating T cells.

Authors:  Fiamma Salerno; Aurelie Guislain; Julian J Freen-Van Heeren; Benoit P Nicolet; Howard A Young; Monika C Wolkers
Journal:  Oncoimmunology       Date:  2018-10-22       Impact factor: 8.110

Review 7.  Trial watch: Immune checkpoint blockers for cancer therapy.

Authors:  Claire Vanpouille-Box; Claire Lhuillier; Lucillia Bezu; Fernando Aranda; Takahiro Yamazaki; Oliver Kepp; Jitka Fucikova; Radek Spisek; Sandra Demaria; Silvia C Formenti; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2017-08-31       Impact factor: 8.110

Review 8.  Trial Watch: Immunostimulatory monoclonal antibodies for oncological indications.

Authors:  Mariona Cabo; Rienk Offringa; Laurence Zitvogel; Guido Kroemer; Aura Muntasell; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2017-08-30       Impact factor: 8.110

Review 9.  Tumour heterogeneity and metastasis at single-cell resolution.

Authors:  Devon A Lawson; Kai Kessenbrock; Ryan T Davis; Nicholas Pervolarakis; Zena Werb
Journal:  Nat Cell Biol       Date:  2018-11-26       Impact factor: 28.824

Review 10.  Revolutionizing Cancer Immunology: The Power of Next-Generation Sequencing Technologies.

Authors:  Meromit Singer; Ana C Anderson
Journal:  Cancer Immunol Res       Date:  2019-02       Impact factor: 11.151

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.